iSpecimen Inc (ISPC)
4.34
-0.24
(-5.24%)
USD |
NASDAQ |
Nov 22, 16:00
4.34
0.00 (0.00%)
After-Hours: 19:58
iSpecimen Total Liabilities (Quarterly): 6.550M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.550M |
| June 30, 2024 | 5.813M |
| March 31, 2024 | 5.701M |
| December 31, 2023 | 6.078M |
| September 30, 2023 | 3.589M |
| June 30, 2023 | 2.860M |
| March 31, 2023 | 3.855M |
| December 31, 2022 | 4.308M |
| September 30, 2022 | 5.516M |
| Date | Value |
|---|---|
| June 30, 2022 | 5.100M |
| March 31, 2022 | 5.62M |
| December 31, 2021 | 5.928M |
| September 30, 2021 | 5.531M |
| June 30, 2021 | 8.926M |
| March 31, 2021 | 37.04M |
| December 31, 2020 | 33.49M |
| September 30, 2020 | 31.74M |
| December 31, 2019 | 26.93M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.860M
Minimum
Jun 2023
37.04M
Maximum
Mar 2021
11.37M
Average
5.757M
Median
Total Liabilities (Quarterly) Benchmarks
| RadNet Inc | 2.156B |
| 23andMe Holding Co | 217.01M |
| Delcath Systems Inc | 23.11M |
| CytoSorbents Corp | 34.80M |
| Progyny Inc | 225.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.26M |
| Shareholders Equity (Quarterly) | 4.715M |
| Debt to Equity Ratio | 0.1834 |
| Current Ratio | 0.7431 |
| Net Debt Paydown Yield | -4.43% |